Karen Baker

Karen Baker

Auto-generated profile, based on publicly available information

Karen Baker

Division of Urology, Duke University, Durham, NC

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2022 in JCO Oncology Practice
Verified
Journal Article
Closed access
AKAnne E. Kim
Anne E. Kim
ANAriel Nelson
Ariel Nelson
KSKyle Stimpert
Kyle Stimpert
RFRebecca L. Flyckt
Rebecca L. Flyckt
NTNannan Thirumavalavan
Nannan Thirumavalavan
Christopher HoimesChristopher Hoimes
Christopher Hoimes
Immune checkpoint inhibition has resulted in significant efficacy across many cancer types, including melanoma. Melanoma is the second most common cancer among those of reproductive age, yet the reproductive toxicities of adjuvant and first-line immunotherapy are largely unknown.The normal innate and adaptive immune systems play a vital role in reproductive organ homeostasis of men and women and are essential for implantation, fertility, and a successful pregnancy. The programmed cell death-1 receptor/programmed cell death receptor ligand-1 (PD-1/PD-L1) pathway is essential in several aspects of fertility and pregnancy. Recent studies have largely focused on the role of the PD-1/PD-L1 pathway in fetomaternal tolerance, highlighting the importance of intact immune regulation in promoting a successful pregnancy.In this review, we describe a case of a reproductive-aged female with stage IIIC melanoma who sought guidance on family planning after pembrolizumab therapy. We discuss the known fertility-related toxicities of immune checkpoint inhibitors, the potential targets for reproductive toxicity in males and nonpregnant females, and the implications of anti–PD-1 therapy in relation to fetomaternal tolerance. Informed decision making will benefit from data and consensus.

29 October 2021 in Transplantation and Cellular Therapy
Verified
Journal Article
Open access
RPRachel Phelan
Rachel Phelan
AIAnnie Pearl Im
Annie Pearl Im
RHRebecca L. Hunter
Rebecca L. Hunter
YIYOSHIHIRO INAMOTO
YOSHIHIRO INAMOTO
MLMaria Teresa Lupo-Stanghellini
Maria Teresa Lupo-Stanghellini
ATAndré Tichelli
André Tichelli
Male-specific late effects after hematopoietic cell transplantation (HCT) include genital chronic graft-versus-host disease (GvHD), hypogonadism, sexual dysfunction, infertility, and subsequent malignancies, such as prostate, penile, and testicular cancer. They may be closely intertwined and cause prolonged morbidity and decreased quality of life after HCT. Here, we provide a systematic review of male-specific late effects in a collaboration between transplant physicians, endocrinologists, urologists, dermatologists, and sexual health professionals through the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research, and the Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation. We utilized systematic review methodology to summarize incidence, risk factors, screening, prevention and treatment of these complications and provide consensus evidence-based recommendations for clinical practice and future research. Most of the evidence regarding male GvHD is still based on limited data, precluding strong therapeutic recommendations. We therefore recommend to systematically screen for male genital GvHD regularly and report it to large registries to allow for a better understanding. Future research should also address treatment since little published evidence is available to date. Male-specific endocrine consequences of HCT include hypogonadism which may also affect bone health. Since the evidence is scarce, current recommendations for hormone substitution and/or bone health treatment are based on similar principles as for the general population. Following HCT, sexual health decreases and this topic should be addressed at regular intervals. Future studies should focus on interventional strategies to address sexual dysfunction. Infertility remains prevalent in patients having undergone myeloablative conditioning, which warrants offering sperm preservation in all HCT candidates. Most studies on fertility rely on descriptive registry analysis and surveys, hence the importance of reporting post-HCT conception data to large registries. Although the quality of evidence is low, the development of cancer in male genital organs does not seem more prevalent than in the general population; however, subsequent malignancies in general seem to be more prevalent in males than females, and special attention should be given to skin and oral mucosa. Male-specific late effects, probably more under-reported than female-specific complications, should be systematically considered during the regular follow-up visits of male survivors who have undergone HCT. Care of patients with male-specific late effects warrants close collaboration between transplant physicians and specialists from other involved disciplines. Future research should be directed towards better data collection on male-specific late effects and on studies about the interrelationship between these late effects, to allow the development of evidence based effective management practices.

1 September 2016 in AIDS Patient Care and STDs
Verified
Journal Article
Open access
EEEva Enns
Eva Enns
CRCavan S. Reilly
Cavan S. Reilly
BVBeth A. Virnig
Beth A. Virnig
KBKaren Baker
Karen Baker
NVNicholas Vogenthaler
Nicholas Vogenthaler
KHKeith Henry
Keith Henry
Retention in care is essential to the health of people living with HIV and also for their communities. We sought to quantify the value of integrating HIV surveillance data with clinical records for improving the accuracy of retention-in-care estimates and the efficiency of efforts to re-engage out-of-care patients. Electronic medical records (EMRs) of HIV+ patients ≥18 years old from a public, hospital-based clinic in Minneapolis, MN between 2008 and 2014 were merged with state surveillance data on HIV-related laboratory tests, out-of-state relocation, and mortality. We calculated levels of retention and estimated the number of required case investigations to re-engage patients who appeared to be out of care over the study period with and without surveillance data integration. Retention was measured as the proportion of years in compliance with Health Resources and Services Administration (HRSA) guidelines (two clinical encounters >90 days apart annually) and the proportion of patients experiencing a gap in care >12 months. With data integration, retention estimates improved from an average HRSA compliance of 70.3% using EMR data alone to 77.5% with surveillance data, whereas the proportion of patients experiencing a >12-month gap in care decreased from 45.0% to 34.4%. If case investigations to re-engage patients were initiated after a 12-month gap in care, surveillance data would avoid 330 (29.3%) investigations over the study period. Surveillance data integration improves the accuracy of retention-in-care estimates and would avert a substantial number of unnecessary case investigations for patients who appear to be out of care but, in fact, receive care elsewhere or have died.

17 March 2022 in F&S Reports
Verified
Journal Article
Open access
KBKaren C. Baker
Karen C. Baker
ASAnne Z. Steiner
Anne Z. Steiner
KHKarl R. Hansen
Karl R. Hansen
KBKurt T. Barnhart
Kurt T. Barnhart
MCMarcelle I. Cedars
Marcelle I. Cedars
HZHeping Zhang
Heping Zhang
To determine the reproducibility of the World Health Organization Fifth Edition (WHO5) strict grading methodology by comparing the percentage of morphologically normal sperm (PNS) recorded by the core laboratory with results obtained at the fertility centers participating in a multisite clinical trial. Secondary cohort analysis of data from the Males, Antioxidants, and Infertility trial. Fertility centers. Semen values of 171 men participating in a multicenter, double-blind, randomized, placebo-controlled trial evaluating the effect of antioxidants on male fertility. Not applicable. Strict morphology expressed as PNS as determined at each fertility center and the core central laboratory for the same semen sample. No correlation was found in the PNS values for the same semen sample between the core laboratory and fertility center laboratories either as a group or by individual site. Interobserver agreement was similarly low (κ = 0.05 and 0.15) between the core and fertility laboratories as a group for strict morphology, categorized by the WHO5 lower reference limits of 4% and 0, respectively. Moderate agreement was found between the core and 2 individual fertility laboratories for the cutoff value of 0 (κ = 0.42 and 0.57). The remainder of the comparisons demonstrated poor to fair agreement. Strict morphology grading using the WHO5 methodology demonstrated overall poor reproducibility among a cohort of experienced fertility laboratories. This lack of correlation and agreement in the PNS values calls into question the reproducibility, and thereby the potential applicability, of sperm strict morphology testing.

1 February 2017 in Journal of Pain and Symptom Management
Verified
Journal Article
Closed access
AMAmbereen Mehta
Ambereen Mehta
JCJennifer Cheng
Jennifer Cheng
ACAnn Cohen-Berger
Ann Cohen-Berger
KBKaren Baker
Karen Baker
SWSteven Wilks
Steven Wilks

2 May 2022 in British Journal of Midwifery
Verified
Journal Article
Open access
KBKaren Baker
Karen Baker
JSJohn Stephenson
John Stephenson
Background National and international guidelines advise active management of the third stage of labour. Studies conducted in obstetric-led units reveal evidence for reductions in primary postpartum haemorrhage with active management compared to expectant management. The association in midwife-led units for low-risk women is relatively untested in the UK. Aims To examine the relationship between third stage of labour management approaches, and incidence of postpartum haemorrhage and severe postpartum haemorrhage in women birthing in midwife-led units. Methods Anonymised data were collected in 2015–2016 from women birthing in England. Adjusted logistic regression was used to assess the effect of management approach on the outcomes of postpartum haemorrhage and severe postpartum haemorrhage, controlling for variables additionally identified as risk factors for postpartum haemorrhage. Results Of the 765 women intending to receive active management and the 508 intending to receive expectant management, 9.54% and 14.0% experienced postpartum haemorrhage respectively (P=0.015). Severe postpartum haemorrhage was experienced by 14 (1.83%) women intending to receive active management and 16 (3.66%) intending to receive expectant management (P=0.134). Conclusions Postpartum haemorrhage, but not severe postpartum haemorrhage, was statistically significantly higher in women birthing in midwife-led units intending to receive expectant management.